ConductScience.org, home

Paper36123738

Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey.

Bradfield Strydom M and 5 others. BMC Womens Health, 2022. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey. Papers, record 36123738. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36123738

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey.
PubMed
Journal
BMC Womens Health
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
2.42
iCite
Revised in PubMed
2022-10-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bradfield Strydom MMoira
2Walpola RLRamesh L
3McMillan SSara
4Khan SSohil
5Ware RSRobert S
6Tiralongo EEvelin

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Candidiasis, VulvovaginalMajor topic
Australia
Female
Humans
Qualitative Research
Sexual Partners
Social Support

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132513647Recurrent vulvovaginal candidiasis.BMJ2020https://conductscience.org/library/papers/32513647PubMed
223104744Recurrent vulvovaginal candidosis among young women in south eastern Nigeria: the role of lifestyle and health-care practices.Int J STD AIDS2012https://conductscience.org/library/papers/23104744PubMed
331640303Association of sexual function and psychological symptoms including depression, anxiety and stress in women with recurrent vulvovaginal candidiasisJ Turk Ger Gynecol Assoc2020https://conductscience.org/library/papers/31640303PubMed
431860575Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans.J Low Genit Tract Dis2020https://conductscience.org/library/papers/31860575PubMed
530625295Clinical diagnosis of endometriosis: a call to action.Am J Obstet Gynecol2019https://conductscience.org/library/papers/30625295PubMed
631270690Influence of recurrent vulvovaginal candidiasis on quality of life issues.Arch Gynecol Obstet2019https://conductscience.org/library/papers/31270690PubMed
721051852Management of recurrent vulvo-vaginal candidosis as a chronic illness.Gynecol Obstet Invest2010https://conductscience.org/library/papers/21051852PubMed
826001874Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.J Obstet Gynaecol Can2015https://conductscience.org/library/papers/26001874PubMed
933596903Conversations between women with vulval lichen sclerosus: a thematic analysis of online forums.BMC Womens Health2021https://conductscience.org/library/papers/33596903PubMed
1024612727Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.BMC Womens Health2014https://conductscience.org/library/papers/24612727PubMed
1127129474Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.Health Qual Life Outcomes2016https://conductscience.org/library/papers/27129474PubMed
1234081319Evidence-based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis.Aust N Z J Obstet Gynaecol2021https://conductscience.org/library/papers/34081319PubMed
1333115430
The relationship between having a regular general practitioner (GP) and the experience of healthcare barriers: a cross-sectional study among young people in NSW, Australia, with oversampling from marginalised groups.
BMC Fam Pract2020https://conductscience.org/library/papers/33115430PubMed
1428299777Recurrent vulvovaginal candidiasis: A review of guideline recommendations.Aust N Z J Obstet Gynaecol2017https://conductscience.org/library/papers/28299777PubMed
1531446677The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis.BJOG2019https://conductscience.org/library/papers/31446677PubMed
1622579433Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis--results of a practitioner survey.Complement Ther Med2012https://conductscience.org/library/papers/22579433PubMed
1724119427Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA.Health Qual Life Outcomes2013https://conductscience.org/library/papers/24119427PubMed
1826164695Recurrent vulvovaginal candidiasis.Am J Obstet Gynecol2016https://conductscience.org/library/papers/26164695PubMed
1935005777Treatment for recurrent vulvovaginal candidiasis (thrush).Cochrane Database Syst Rev2022https://conductscience.org/library/papers/35005777PubMed
2030078662Global burden of recurrent vulvovaginal candidiasis: a systematic review.Lancet Infect Dis2018https://conductscience.org/library/papers/30078662PubMed

See all 28 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42768343Latent profile analysis of stigma and medical coping among patients with vaginitis: a cross-sectional study.BMC Womens Health2026https://conductscience.org/library/papers/42768343PubMed
42189444Treatment recommendations for recurrent vulvovaginal candidiasis across complementary and conventional disciplines: a national survey of Australian healthcare professionals.Int J Clin Pharm2026https://conductscience.org/library/papers/42189444PubMed
41784366Contribution of fungal diseases to the U.S. chronic disease burden.Clin Microbiol Rev2026https://conductscience.org/library/papers/41784366PubMed
41731507Cervicovaginal lavage fluid iron and manganese levels in women with and without vaginitis.BMC Womens Health2026https://conductscience.org/library/papers/41731507PubMed
41628983'It's not just thrush, it's recurrent thrush': a qualitative study of patient and clinician perspectives on diagnosing recurrent vulvovaginal candidiasis.Br J Gen Pract2026https://conductscience.org/library/papers/41628983PubMed
41592856Accumulative experiences of recurrent vulvovaginal thrush: a qualitative study of primary care navigation from patient and clinician perspectives.Br J Gen Pract2026https://conductscience.org/library/papers/41592856PubMed
41420368Attending to Gyn-Ecology: Managing the 'Mess' of Recurrent Vulvovaginal Thrush.Sociol Health Illn2026https://conductscience.org/library/papers/41420368PubMed
40809668Benign Mesenchymal Tumor of the Vulva: A Case Report and Narrative Review of the Literature.Cureus2025https://conductscience.org/library/papers/40809668PubMed
40612985Economic burden of recurrent vulvovaginal candidiasis in Uganda: a cost-of-illness analysis.IJID Reg2025https://conductscience.org/library/papers/40612985PubMed
40434101Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations.Clin Microbiol Rev2025https://conductscience.org/library/papers/40434101PubMed
39997277Knowledge of Vulvovaginal Candidiasis Characteristics, Signs, Symptoms, and Appropriate Treatment Among Portuguese Pharmacy Professionals.Healthcare (Basel)2025https://conductscience.org/library/papers/39997277PubMed
39586933The impact of fluconazole use on the fungal and bacterial microbiomes in recurrent Vulvovaginal Candidiasis (RVVC): a pilot study of vaginal and gastrointestinal site interplay.Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/39586933PubMed
37635435Intravaginal Combination Therapy of Acetic and Lactic Acid in premenopausal women with recurrent vulvovaginal candidiasis: A randomized, double-blind placebo-controlled feasibility trial.Womens Health (Lond)2023https://conductscience.org/library/papers/37635435PubMed
37375446Epidemiological Profile of Patients with Vulvovaginal Candidiasis from a Sexually Transmitted Infection Clinic in Southern Spain.Pathogens2023https://conductscience.org/library/papers/37375446PubMed
36539841Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study.Eur J Med Res2022https://conductscience.org/library/papers/36539841PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTPN65777PubTator's text mininghttps://conductscience.org/library/genes/5777

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36123738

GET https://conductscience.org/api/papers/v1/36123738/references?page=2